Landmark ASCO results and advances in liquid biopsy-driven treatment switching spotlight innovation in cancer research and personalized medicine.
Landmark ASCO results and advances in liquid biopsy-driven treatment switching spotlight innovation in cancer research and personalized medicine.
Results from the Sunrise-1 trial suggest a new option for patients with second-line papillary non-muscle invasive bladder cancer
New data from India suggest that Hillchol, an oral cholera vaccine by Bharat Biotech, is safe, effective and …
Early-phase trial data for a theranostic radiopharmaceutical, 177Lu-NeoB, demonstrate safety and potential tumour control in patients with GRPR-positive …
Phase III SEQUOIA-HCM analyses show aficamten offers benefit to patients with varying symptom severity and across regions, opening …
In May 2025, a gene therapy for Rett syndrome has cleared major regulatory design review and is activating …
New oral vaccine succeeds against multiple cholera strains offering promise for broad use in endemic regions
New antibody therapeutic enters Phase 1 with hopes of helping women with hot flashes and night sweats
Mid-stage results show meaningful reductions in pathological protein, setting stage for later-phase trials
Combination of avutometinib and defactinib offers new option where chemotherapy has often failed
Already a subscriber? Log in